BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Chronic hepatitis c
1
Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways
11/24/2023 6:10:12 AM | Browse: 184 | Download: 669
2
Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report
10/25/2023 8:49:11 AM | Browse: 234 | Download: 582
3
Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients
6/9/2022 7:17:55 AM | Browse: 448 | Download: 1668
4
Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
1/21/2022 8:16:14 AM | Browse: 530 | Download: 1078
5
Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study
11/10/2021 7:13:09 AM | Browse: 712 | Download: 1053
6
Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis
5/14/2021 10:27:31 AM | Browse: 626 | Download: 1253
7
Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study
5/10/2021 7:46:10 AM | Browse: 447 | Download: 1191
8
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond
4/29/2021 2:12:02 AM | Browse: 503 | Download: 1044
9
Production and activity of metalloproteinases during liver fibrosis progression of chronic hepatitis C patients
2/25/2021 3:45:30 PM | Browse: 747 | Download: 1641
10
Management of hepatitis C in children and adolescents during COVID-19 pandemic
8/25/2020 9:16:00 AM | Browse: 753 | Download: 1394
11
Liver-related effects of chronic hepatitis C antiviral treatment
6/14/2020 1:45:26 PM | Browse: 941 | Download: 1645
12
Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus
4/23/2020 10:34:55 AM | Browse: 644 | Download: 1785
13
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
1/13/2020 11:27:12 AM | Browse: 1162 | Download: 1561
14
Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy
8/26/2019 2:56:47 AM | Browse: 815 | Download: 2191
15
High prevalence of occult hepatitis C infection in predialysis patients
1/27/2019 7:04:05 AM | Browse: 889 | Download: 1624
16
Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
10/12/2018 5:32:21 AM | Browse: 780 | Download: 1171
17
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
3/26/2018 8:48:04 AM | Browse: 1301 | Download: 2577
18
Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis
1/26/2018 8:09:36 AM | Browse: 1113 | Download: 1723
19
Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1
12/27/2017 10:31:19 AM | Browse: 1143 | Download: 2070
20
Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment
7/7/2017 11:41:16 AM | Browse: 1074 | Download: 2095
21
Interferon related pericarditis: Review
6/26/2017 12:49:43 AM | Browse: 1122 | Download: 1464
22
Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting
6/14/2017 9:25:57 AM | Browse: 1100 | Download: 2123
23
Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
6/7/2017 7:22:42 AM | Browse: 1849 | Download: 3451
24
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
5/17/2017 6:29:40 AM | Browse: 1411 | Download: 2150
25
Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b
4/6/2017 6:30:00 PM | Browse: 1234 | Download: 1798
26
Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C
2/27/2017 8:50:00 AM | Browse: 1223 | Download: 1690
27
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
2/17/2017 8:32:00 AM | Browse: 1195 | Download: 1717
28
Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
11/26/2016 6:56:00 PM | Browse: 1195 | Download: 2463
29
Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature
11/6/2016 3:43:00 PM | Browse: 980 | Download: 1430
30
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy
10/14/2016 1:37:00 PM | Browse: 1253 | Download: 1474
31
Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C
9/30/2016 5:59:00 PM | Browse: 1220 | Download: 2296
32
Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
9/4/2016 2:49:00 PM | Browse: 1408 | Download: 2005
33
Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles
7/29/2016 8:32:00 PM | Browse: 1161 | Download: 1776
34
Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
4/19/2016 9:45:00 AM | Browse: 1236 | Download: 2768
35
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
3/23/2016 4:26:00 PM | Browse: 1399 | Download: 2276
36
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage
1/20/2016 5:04:00 PM | Browse: 1314 | Download: 1560
37
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus -infected liver
12/10/2015 10:35:00 AM | Browse: 1168 | Download: 1505
38
Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching
12/4/2015 3:24:00 PM | Browse: 1188 | Download: 2359
39
Treatment of chronic hepatitis C in patients with HIV/HCV coinfection
12/2/2015 12:06:00 PM | Browse: 588 | Download: 1047
40
Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C
11/18/2015 11:12:00 AM | Browse: 1090 | Download: 1342
41
Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C
11/18/2015 11:12:00 AM | Browse: 1135 | Download: 1879
42
Era of direct acting antivirals in chronic hepatitis C: Who will benefit?
10/30/2015 11:57:00 AM | Browse: 1536 | Download: 1823
43
Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals
10/14/2015 12:06:00 PM | Browse: 1232 | Download: 1709
44
Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment
9/23/2015 12:28:00 PM | Browse: 1815 | Download: 2057
45
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
8/8/2015 3:25:00 PM | Browse: 1156 | Download: 2337
46
Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-pacific hepatitis C virus genotype 1 non-responders/relapsers
7/30/2015 11:19:00 AM | Browse: 1316 | Download: 1771
47
Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: a case report and systematic review of literature
6/29/2015 5:40:00 PM | Browse: 1041 | Download: 1684
48
Impact of direct acting antiviral-based triple therapy on the serum alpha-fetoprotein level
4/30/2015 2:11:00 PM | Browse: 1091 | Download: 1871
49
Management of hepatitis C infection before and after liver transplantation
4/30/2015 2:11:00 PM | Browse: 1130 | Download: 1640
50
Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C
4/7/2015 6:08:00 PM | Browse: 1078 | Download: 1802